Introduction
T cells play a central role in regulating cell-mediated and demonstrate a predominant T h 1 cytokine secretion profile, although some susceptible strains of mice activate IL-4-humoral immune responses to microbial pathogens through the release of specific cytokines. In animal models, two producing T h 2 cells to a certain extent in response to the infection (11,12). IFN-γ has powerful immunomodulatory and functional subpopulations of CD4 ϩ helper T (T h ) cells, distinguished by their patterns of cytokine production, contribute to macrophage-activating properties (13-15), and plays an essential role in protective immunity against these intracellular these responses (1, 2) . T h 1 cells orchestrate delayed-type hypersensitivity responses through secretion of IFN-γ, IL-2 pathogens (16), as convincingly demonstrated in recent experiments with IFN-γ and IFN-γ receptor gene-disrupted and tumor necrosis factor-β. T h 2 cells enhance antibody production through production of IL-4, IL-5, IL-10 and IL-13 mice (17-19).
The specific antigens eliciting protective T cell responses (3-8).
The interaction between specifically sensitized T cells and
are not yet known for tuberculosis, although a considerable number of proteins has been identified by classical purification activated macrophage-effector cells is considered to be the hallmark of protective immunity against the pathogenic methods and particularly by recombinant DNA technology (20) (21) (22) . One of the secreted antigens from M. tuberculosis mycobacteria Mycobacterium tuberculosis and Mycobacterium leprae (9, 10) . Mice infected with live BCG also is MPT59 (23) . MPT59 is also known as α antigen or antigen 85B and manifested itself as one of the most potent antigens of CHO cells that had been transfected with mIL-5 cDNA as described (33) . in the species of purified antigens tested.
Our major interests are to understand how T h 1 cells develop mAb after infection or immunization with M. tuberculosis, to identify key T cell populations involved in this response and to
The following mAb were used: RL172.4 (34) and GK1.5 mAb (35) , which recognize CD4 (ATCC, Rockville, MD); RA3-6B2 characterize antigenic epitopes for their activation. We have shown that immunization of mice with killed M. tuberculosis mAb (36) , which recognizes B220 (ATCC); 53-6.72 mAb (37) and 3.155 (38) , which recognize CD8 (ATCC); 2.4G2 mAb can induce the development of three functionally distinct subsets of purified protein derivative (PPD)-reactive CD4 ϩ T h (39) , which recognizes FcγR (ATCC); M5/114.15.2 (40) (anti-I-A b ) and 28-16-8S (41) (anti-I-A b ) (kindly provided by Dr T. cells for B cell triggering (24, 25) . Since PPD has been shown to be a complex of various proteins, we searched for a Nakayama, University of Tokyo). B20.6 (42) (anti-V β 2), 44-22-1 (43) (anti-V β 6) and F23. 1 (44) (anti-V β 8) were kindly provided homogeneously purified protein antigen which can induce a particular set of T cell response in M. tuberculosis-primed or by Dr Y. Yoshikai (Nagoya University, Nagoya). KJ-25 (45) (anti-V β 3) was purchased from PharMingen (San Diego, CA). -infected mice. To identify key T cell populations involved in this powerful response and to characterize the nature of the MR9-4 (46) (anti-V β 5), MR10.2 (anti-V β 9) (47) and RR3-15 (48) (anti-V β 11) were kindly provided by Dr O. Kanagawa antigens responsible for their activation, we evaluated TCR β chain V region gene usage in M. tuberculosis-primed cells, (Washington University, St. Louis, MO) and Dr H. Nakauchi (Tsukuba University, Tsukuba). Phycoerythrin (PE)-labeled because selection of T cells by nominal antigen requires TCR composed of specific V α and V β chains (26) . In the present streptavidin (PE-av) was purchased from Gibco/BRL (Grand Island, NY). Normal rat IgG and normal hamster IgG were study, we describe the characteristics of T cells which recognize the antigen MPT59 purified from cultured fluid of M.
purified from sera with caprylic acid (Sigma) as described (33) . tuberculosis. We also identified the antigenic epitopes on MPT59. Finally, we discuss the TCR V β usage of MPT59-
The following anti-cytokine mAb were used: 11B11 (49), which neutralizes IL-4 (kindly provided by Dr W. E. Paul, reactive T h 1 cells.
National Institutes of Health, Bethesda, MD); BVD6-24G2 (50), which recognizes IL-4 (PharMingen); SXC-1 and 2A5 (50, Methods 51), which neutralize IL-10 (kindly provided by Dr M. Howard, DNAX Research Institute, Palo Alto, CA); NC17 mAb (52), Mice which recognizes mIL-5; RA4-6A2 (PharMingen), which neutMice of the C57BL/6 (B6) and B10.A(4R) strains were purralizes IFN-γ; XMG1.2 (53) (anti-IFN-γ, kindly provided by Dr chased from Japan SLC (Hamamatsu, Japan) and the Jack-M. Howard); and S4B6 (1) (anti-mIL-2) which was kindly son Laboratory (Bar Harbor, ME) respectively. C58J and provided by Dr H. Nariuchi (University of Tokyo). B10.A(3R) mice were kindly provided by Dr A. Matsuzawa Immunization (University of Tokyo, Tokyo) and Dr T. Nakayama (University of Tokyo) respectively. BALB.B mice, originally provided by
The various strains of mice were immunized by s.c. injection Dr K. Moriwaki (National Institute of Genetics, Mishima), were with 500 µg of an acetone powder containing heat-killed maintained by brother-sister mating in the animal facility at M. tuberculosis strain H37Rv in paraffin oil at the base of the the Institute of Medical Science, University of Tokyo, under tail (25) . These mice were used subsequently as T cell donors. specific pathogen-free conditions. (B6ϫB10.A(4R))F 1 mice
In some experiments, C57BL/6 and B10.A(3R) mice were were bred in our animal facility.
immunized with 1 µg of synthetic peptide-25 or 10 µg PPD in incomplete Freund's adjuvant at the base of the tail and Antigens and reagents boosted 7 days before the experiments with 10 µg of peptide-25 or 100 µg PPD. Mycobacterium protein fractions of BCG or of M. tuberculosis were purified as described (27) (28) (29) (30) (31) (32) and used at various Cell culture concentrations. Peptides covering the complete mature 285 amino acids long MPT59 protein were synthesized as 15-A single-cell suspension was prepared from inguinal lymph nodes obtained from various strains of mice. To eliminate mers overlapping by five amino acids with the neighboring peptides by Chitron Mimotopes (Victoria, Australia), Dr T.
CD4 ϩ and CD8 ϩ cells, M. tuberculosis-primed cells (2ϫ10 7 / ml) were treated with 50 µg/ml of either anti-CD4 or anti-CD8 Akizawa (Setsunan University, Takatsuki) and Dr S. Ohmi (University of Tokyo). Each peptide was purified using HPLC. mAb plus complement as described previously (54) and used as responding cells. For the proliferation assay, cells (1ϫ10 6 ) Chloroquine and wortmannin were obtained from Sigma (St Louis, MO).
were co-cultured in triplicate with various concentrations of antigens or synthetic peptides in 200 µl/well of complete Mouse IL-2 was purified from conditioned medium of phorbol myristate acetate-stimulated EL-4 as described (25) by medium consisting of RPMI 1640 medium (Sigma) supplemented with 8% FCS, penicillin (100 IU/ml) and streptomycin immunoaffinity chromatography using anti-IL-2 mAb, S4B6 (1) , that was kindly provided by Dr H. Nariuchi (University of (50 µg/ml) placed in each well of a 96-well flat-bottom microtiter plate (Nunc, Roskilde, Denmark IL-2 assay IL-2 activity was determined by a modified microassay method (57) using an IL-2-dependent mouse cytotoxic T cell line, indicated stimuli. Cells were cultured for 72 h. Proliferation CTLL-2. The cells were plated at a final concentration of was determined as described above. 4ϫ10 4 /200 µl/well and were cultured with various dilutions of the test supernatants for 24 h. The cells were pulse-labeled Fixation of APC with 1 µCi/well of [ 3 H]thymidine for the last 6 h of the incubation T cells were enriched by two rounds of removing adherent period. A unit of IL-2 activity was defined as the reciprocal of cells by a Sephadex G-10 column followed by a nylon wool the dilution yielding one-third of the maximal proliferative column as described above. Purity was assessed by the response to a standard IL-2 preparation.
ability of concanavalin A (Con A) to stimulate the non-adherent cells. Con A, which requires only a small percentage of APC Flow cytometry to induce a proliferative response, yielded no stimulation, The expression of cell surface antigens, particularly TCR V β , indicating a relatively APC-free population. Whole spleen cells before and after the culturing was analyzed by flow cytometry.
from non-immunized mice were fixed with 0.2% paraformal-A single-cell suspension prepared from inguinal lymph nodes dehyde for 15 min at 25°C (22) , then washed four times with or cells collected after cell culturing was stained with FITCcomplete media. Fixed spleen cells were added as APC at labeled anti-CD4 mAb and biotinylated anti-V β mAb plus PE-5ϫ10 5 /ml, as were the purified T cells. As a control, the same av (Gibco/BRL) as described previously (55) . 2.4G2 mAb (10 number of irradiated spleen cells was added as APC in µg/ml) was added during the incubation to avoid the nonplace of fixed spleen cells. The proliferative response was specific binding of the labeled mAb. After staining, cells determined as described above. were suspended in buffer containing 7-amino-actinomycin D (Sigma) to exclude dead cells from the analysis. Fluorescence intensity was measured on a FACScan analyzer (BectonResults Dickinson). The gate on the lymphoid population was set by MPT59 is the antigen reactive to M. tuberculosis-primed CD4 ϩ forward and side scatter. To assess particular V β ϩ T cells, we T cells in C57BL/6 mice calculated the percentage of V β ϩ cells from total CD4 ϩ cells. In the first experiment, M. tuberculosis-primed lymph node Antibody blocking experiments cells of B6 mice were cultured with various concentrations of several purified protein antigens from conditioned medium of To evaluate MHC restriction between T cells and antigenpresenting cells (APC), T cells were purified from inguinal M. tuberculosis and M. bovis BCG, and their proliferative responses were evaluated. The cells were also stimulated lymph node cells from (B10.A(4R)ϫB6)F 1 mice by passage through a Sephadex G-10 column twice to eliminate APC with PPD as a control. MPB70 was purified from the culture supernatants of M. bovis BCG, and other protein antigens, from the responder cell population followed by passage through a nylon wool column (58) (59) (60) . The purity of T cells MPT47, MPT57, MPT59 and MPT64, were isolated from the culture fluids of M. tuberculosis strain H37Rv. Among the was Ͼ90%. Purified T cells (5ϫ10 5 ) were co-cultured with 5ϫ10 5 irradiated (3300 rad) spleen cells from either B6 or antigens tested, MPT59 and PPD induced remarkable proliferative responses of M. tuberculosis-primed cells (Fig. 1) . The B10.A(4R) mice as APC in the presence of PPD or MPT59. Anti-I-A b mAb was added to the culture on day 0. Inguinal proliferative responses to MPT59 and PPD were observed in a dose-dependent manner and 1 µg/ml MPT59 was sufficient lymph node cells (5ϫ10 5 ) from (B6ϫB10.A(4R))F 1 mice were pretreated with the antibodies for 1 h prior to addition of the to induce maximum proliferative response. A 10 times higher T cells and APC, T cells purified from M. tuberculosis-primed cells from (B10.A(4R)ϫB6)F 1 mice were stimulated with MPT59 in the presence of irradiated spleen cells derived from each strain of mice. M. tuberculosis-primed F 1 cells concentration of PPD (10 µg/ml) was required to induce the maximum response. Less than 30 ng/ml MPT59 was capable proliferated when stimulated with MPT59 plus APC derived from B6 mice (data not shown) and the addition of anti-I-A b , of stimulating M. tuberculosis-primed cell proliferation, while 1 µg/ml PPD was required to induce a similar extent of but not anti-I-A k mAb to the culture completely abrogated this response, while they did not respond to MPT59 in the presence proliferation (data not shown). Other protein antigens induced marginal proliferative responses even at 10 µg/ml (Fig. 1) .
of APC from B10.A(4R) mice. These results suggest that MPT59 can induce proliferative V β 11 ϩ T cells are expanded by stimulating M. tuberculosisresponse 30-fold more efficient than PPD. Thus, we decided primed cells with MPT59 to use 1 µg/ml MPT59 and 10 µg/ml PPD as antigens. Table 1 . Stimulation of M. tuberculosis-primed increased when M. tuberculosis-primed cells were stimulated with MPT59, while these of V β 11 ϩ T cells in R1 were unchanged cells with MPT59 or PPD induced significant IFN-γ and IL-2 production. Neither IL-4, IL-5 nor IL-10 production was (Table 3) . Unstimulated M. tuberculosis-primed cells did not increase V β 11 ϩ T cells. Furthermore stimulation of non-primed observed under the same culture conditions. We could not detect a significant production of any cytokines in cultured cells with MPT59 did not increase V β 11 ϩ T cells. These data indicate that MPT59 preferentially stimulates V β 11 ϩ CD4 ϩ T supernatants of MPT59-stimulated cells from non-primed mice (data not shown (Fig. 2) . Among the 30 synthetic peptides, we could only use 22 peptides, since the remaining eight primed mice were cultured under the same conditions as controls. M. tuberculosis-primed cells from all strains of mice peptides were insoluble in medium. At first, M. tuberculosis- peptide-9 (p81-95). One hundred nanograms/ml of peptide-25 was able to induce the maximum proliferative response and 5 ng/ml of peptide-25 (amino acids 240-254) was able to induce a significant proliferative response (data not shown). In contrast, proliferative response induced by 25 µg/ml of peptide-9 was~10% of the maximum response induced by peptide-25. Stimulation of lymph node cells from non-primed mice with peptide-25 (amino acids 240-254) again failed to induce proliferative response. Neither peptide-25 (amino acids 240-254) nor peptide-9 (amino acids 81-95) induced a proliferative response on M. tuberculosis-primed cells from BALB/c or C3H/HeN mice. When we examined TCR V β usage of T cells responding to peptide-25 (amino acids 240-254), Ͼ65% of CD4 ϩ blastic T cells expressed V β 11, while peptide-9 (amino acids 81-95) primed lymph node cells from B6 mice were stimulated with failed to induce the expansion of V β 11 ϩ T cells (Table 3 ). In each peptide at a concentration of 25 µg/ml or with 1 µg/ml contrast, percentages of T cells expressing V β 8 and V β 6 were MPT59 and the proliferative responses were determined.
lower than those of T cells in the unstimulated population. Representative results of three independent experiments are These results indicate that peptide-25 (amino acids 240-254) shown in Fig. 3 . Two synthetic peptides (peptide-25 and is at least one of the antigenic epitopes of MPT59 which peptide-9) showed significant stimulatory effects on M. tubercan preferentially stimulate V β 11 ϩ MPT59-reactive T cells in culosis-primed cells. The proliferative responses to peptide -25 M. tuberculosis-primed B6 mice. and peptide-9 were observed in a dose-dependent manner.
To confirm this further, B6 and B10.A(3R) mice were immunPeptide-25 covering amino acid residues of 240-255 (p241-255) of MPT59 always induced a higher response than ized with M. tuberculosis, and their lymph node cells were a Lymph node cells from mice which had been immunized with M. tuberculosis (Tbc) were cultured with 1 µg/ml MPT59 or 0.25 µg/ml peptide-25 (amino acids 240-254). After 3 days, proliferative response was determined by (Fig. 4) . dependent manner, and showed a predominant V β 11 usage of T cells. The maximum proliferative response was induced
In contrast, the T cell response to MPT59, PPD and peptide-25 (amino acids 240-254) was intact in the presence of by peptide-25 and MPT59 at 100 ng/ml and 1 µg/ml respectively (data not shown). The cells from B10.A(3R) showed a irradiated APC. The involvement of proteolytic cleavage of exogenous significant, but a low proliferative response to both MPT59 and peptide-25 (amino acids 240-254). Furthermore, the antigen processing by protease in lysosomes has been shown by many investigators (62) . To further confirm the requirement proportion of V β 11 ϩ T cells was not increased. These results demonstrate that MPT59 and peptide-25 (amino acids 240-of antigen processing of MPT59 and peptide-25 (amino acids 240-254), the effects on the proliferative response of 254) preferentially stimulates MPT59-reactive V β 11 ϩ T cells from M. tuberculosis-primed mice with I-A b .
M. tuberculosis-primed cells were examined using chroloquine and wortmannin, both of which have been shown to Antigen processing of peptide-25 (amino acids 240-254) is prevent antigen presentation by APC (63, 64) . The addition of required for V β 11 ϩ M. tuberculosis-primed T cell stimulation chroloquine and wortmannin at the beginning of cultures of M. tuberculosis-primed cells significantly suppressed MPT59-To determine whether responses to MPT59 and its related polypeptides required antigen processing, paraformaland peptide-25-induced proliferation of M. tuberculosis- primed T cells, while the same treatment did not affect SEAinduced proliferation (Table 5) . Therefore, we concluded that MPT59 and peptide-25 (amino acids 240-254) are not superantigens.
Peptide-25 (amino acids 240-254) of MPT59 can induce in vivo peptide-specific V β 11 ϩ T cell development We next asked whether or not peptide-25 (amino acids 240-254) is immunogenic in vivo. Two groups of five B6 mice were immunized with peptide-25 (amino acids 240-254) or MPT59 and boosted with the same antigen 4 weeks later. Seven days after the booster injection, the proliferative response of lymph node cells from immunized mice was examined. As shown in Table 6 , lymph node cells from B6 mice which had been immunized with peptide-25 (amino acids 240-254) and MPT59 responded to relevant antigen for proliferation, while those from non-immunized mice did not respond to peptide-25 Tables 1 and 2 ). MHC-restricted interactions between primed cells to proliferate when added at higher concentrations (data not shown). These results suggest that 11-mer MPT59-reactive CD4 ϩ T cells and MPT59-presenting cells were required, and the processing of MPT59 in APC with Ipeptides (AYNAAGGHNAV) are able to induce proliferative response of M. tuberculosis-primed cells from I-A b mice. A b was essential for the response (Table 5 and Fig. 4 ). MPT59 stimulated preferentially V β 11 ϩ CD4 ϩ MPT59-reactive T cells Over the past several years a number of studies have attempted to search for T cell determinants on various antiin M. tuberculosis-primed mice (Tables 3 and 4 ). An antigenic epitope [peptide-25 (amino acids 240-254)] of MPT59 which gens. Common structures or specific alignment of amino acids on peptides are required for binding to certain MHC preferentially stimulated V β 11 ϩ T h 1 cells in M. tuberculosisprimed mice was mapped (Fig. 3) . Peptide-25 (amino acids molecules (motif) (70) . Unlike MHC class I-bound peptides, demonstration of a distinct specific motif of peptides for 240-254) was immunogenic in vivo and induced preferential generation of V β 11 ϩ T h 1 cells (Table 7) . the particular class II MHC molecule has been hampered. However, some motifs for particular class II MHC molecules Unlike nominal antigens, which stimulate a small fraction of T cells, superantigens stimulate the majority of T cells bearing have emerged. Peptide-25 (amino acids 240-254) contained a similar motif (Y-x-x-x-x-x-x-x-A) to the I-A b motif (F-x-x-x-xa TCR encoded by a specific V region polypeptide chain (65) (66) (67) (68) (69) . This extensive stimulation of whole sets of T cells
x-x-x-A), described by Itoh et al. (71) , while peptide-9 (amino acids 81-95) did not contain a I-A b motif. Peptide-30 (amino results in systemic manifestations of disease. Recent analysis of the TCR V β repertoire expressed in patients with tubercuacids 286-300) contains another I-A b motif (N-x-x-x-x-x-P) described by Rudenski et al. (72) , but it shows little stimulatory losis pleuritis revealed the presence of a superantigen in M. tuberculosis (22) . Superantigens have been shown to activity. To examine the anchoring role of Y at position 244, we made an alanine substitution at this position (peptide-25-activate naive T cells in a manner that does not require processing in APC. Although MPT59 and peptide-25 (amino 5). Stimulatory activity of peptide-25-5 on MPT59-reactive V β 11 ϩ T cells was Ͻ20% of peptide-25 (amino acids 240-acids 240-254) induce proliferation of V β 11 ϩ CD4 ϩ MPT-59-reactive T cells in an I-A b -restricted manner, they can stimulate 254) and was only observed at higher concentrations (Ͼ25 µg/ml) (data not shown). To get a further insight into the cells only from M. tuberculosis-primed mice and require processing by APC. We therefore conclude that MPT59 and anchoring role of Y at position 244 in peptide-25 (amino acids 240-254), we are currently pursuing more precise analysis peptide-25 (amino acids 240-254) are not superantigens. Interestingly, lymph node cells from B10.A(3R) mice immunusing PPD-reactive V β 11 ϩ cloned T cell lines by stimulating the substitution mutant (peptide-25-5). ized with M. tuberculosis responded to a certain extent to MPT59 (Table 2) , whereas they showed little, if any, proliferatMycobacteria have long been recognized for having power-
